Recap: Bristol-Myers Squibb Q2 Earnings

Comments
Loading...

 

Bristol-Myers Squibb BMY reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Bristol-Myers Squibb beat estimated earnings by 6.04%, reporting an EPS of $1.93 versus an estimate of $1.82.

Revenue was up $184.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 2.5% drop in the share price the next day.

Here's a look at Bristol-Myers Squibb's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 1.91 1.80 1.92 1.91
EPS Actual 1.96 1.83 2 1.93
Revenue Estimate 11.36B 12.08B 11.58B 11.33B
Revenue Actual 11.65B 11.98B 11.62B 11.70B

To track all earnings releases for Bristol-Myers Squibb visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMY Logo
BMYBristol-Myers Squibb Co
$54.78-4.24%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum82.38
Growth35.03
Quality-
Value14.32
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: